BioSpace News Archive

AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024.

STAAR Surgical Company, a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses for myopia, astigmatism and presbyopia, reported financial results for the first quarter ended March 29, 2024.

YS Biopharma Co., Ltd. announced that it will hold an Extraordinary General Meeting of the Company at the 35th Floor, Two Exchange Square, 8 Connaught Place, Central, Hong Kong, at 9:00 a.m. on May 21, 2024, with an option for Zoom dial-in.

McKesson Corporation (NYSE: MCK) has released its fiscal 2024 fourth quarter financial results.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that Eric Crombez, M.D., the company’s chief medical officer and executive vice president, will participate in a fireside at Bank of America’s 2024 Healthcare Conference on Tuesday, May 14, 2024, at 1:40 p.m. PT.

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported financial results for the first quarter ended March 31, 2024, and provided a business update.

Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, reported financial results for the first quarter, which ended March 31, 2024, and provided an update on recent developments in its business.

Masimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 30, 2024.

Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the first quarter ended March 31, 2024.

Jasper Therapeutics, Inc. announced that its management will present at the following upcoming investor conferences in May.